Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics.

Bots ML, Evans GW, Riley W, Meijer R, McBride KH, Paskett ED, Helmond FA, Grobbee DE; OPAL Investigators.

Control Clin Trials. 2003 Dec;24(6):752-75.

PMID:
14662281
2.
3.

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.

Langer RD, Landgren BM, Rymer J, Helmond FA; OPAL Investigators.

Am J Obstet Gynecol. 2006 Nov;195(5):1320-7. Epub 2006 Jul 26.

PMID:
16875644
4.

Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study.

Dogan S, Plantinga Y, Evans GW, Meijer R, Grobbee DE, Bots ML; OPAL investigators.

Curr Med Res Opin. 2009 Jan;25(1):109-22. doi: 10.1185/03007990802589727 .

PMID:
19210144
5.

Striking increases in carotid artery wall thickness in healthy subjects.

Meijer R, Störk S, Evans GW, Grobbee DE, Bots ML.

Cerebrovasc Dis. 2010;30(5):448-55. doi: 10.1159/000319572. Epub 2010 Aug 19.

PMID:
20720415
6.

A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.

Thiébaud D, Bigler JM, Renteria S, Pache T, Welti HJ, Landry M, Burckhardt P.

Climacteric. 1998 Sep;1(3):202-10.

PMID:
11907945
7.

Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.

Dogan S, Plantinga Y, Crouse JR 3rd, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML; METEOR Study Group.

J Hypertens. 2011 Nov;29(11):2181-93. doi: 10.1097/HJH.0b013e32834b0eba.

PMID:
21918474
8.
9.
10.

[Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].

Reginster JY.

J Gynecol Obstet Biol Reprod (Paris). 2002 Oct;31(6):541-9. Review. French.

11.

Effects of tibolone on bone quality in ovariectomized monkeys.

Lees CJ, Ederveen AG, Spanjers CP, Clarkson TB.

Menopause. 2005 Sep-Oct;12(5):613-8. Epub 2005 Sep 1.

PMID:
16145316
12.
13.

Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.

Yang TS, Tsan SH, Chen CR, Chang SP, Yuan CC.

Zhonghua Yi Xue Za Zhi (Taipei). 1999 May;62(5):308-15.

PMID:
10389286
14.

Association between Lumbar Bone Mineral Density and Carotid Intima-Media Thickness in Korean Adults: a Cross-sectional Study of Healthy Twin Study.

Shin J, Park JH, Song YM, Lee K, Sung J.

J Korean Med Sci. 2017 Jan;32(1):70-76. doi: 10.3346/jkms.2017.32.1.70.

15.

Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women.

Reginster JY, Agnusdei D, Gennari C, Kicovic PM.

Gynecol Endocrinol. 1999 Oct;13(5):361-8.

PMID:
10599554
16.

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.

Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML; METEOR Study Group.

JAMA. 2007 Mar 28;297(12):1344-53. Epub 2007 Mar 25.

PMID:
17384434
17.
18.

Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia.

Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJ, Shear CL, Evans GW, Visseren FL, Bots ML; Radiance 1 and Radiance 2 Study Groups.

Ann Med. 2010 Sep;42(6):447-64. doi: 10.3109/07853890.2010.499132.

PMID:
20645885
19.

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators.

JAMA. 2003 Oct 1;290(13):1729-38.

PMID:
14519707
20.

Carotid artery intima-media thickness after raloxifene treatment.

Mack WJ, Dhungana B, Dowsett SA, Keech CA, Feng M, Li Y, Hodis HN.

J Womens Health (Larchmt). 2007 Apr;16(3):370-8.

PMID:
17439382

Supplemental Content

Support Center